SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jacopo Vittoriano Bizzarri, Giancarlo Giupponi, Ignazio Maniscalco, Patrizia Schroffenegger, Andreas Conca, Hans Peter Kapfhammer, Parkinson-Krankheit und Psychosen, neuropsychiatrie, 2015, 29, 1, 1

    CrossRef

  2. 2
    Kurt A. Jellinger, Cerebral correlates of psychotic syndromes in neurodegenerative diseases, Journal of Cellular and Molecular Medicine, 2012, 16, 5
  3. You have free access to this content3
    Lothar Burghaus, Carsten Eggers, Lars Timmermann, Gereon R. Fink, Nico J. Diederich, Hallucinations in Neurodegenerative Diseases, CNS Neuroscience & Therapeutics, 2012, 18, 2
  4. 4
    Manuel F. Casanova, Sergio E. Starkstein, Kurt A. Jellinger, Clinicopathological correlates of behavioral and psychological symptoms of dementia, Acta Neuropathologica, 2011, 122, 2, 117

    CrossRef

  5. 5
    Christopher G. Goetz, Glenn T. Stebbins, Bichun Ouyang, Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years, Movement Disorders, 2011, 26, 12
  6. 6
    Jim Barnes, Vince Connelly, Luci Wiggs, Laura Boubert, Ksenija Maravic, Sleep Patterns in Parkinson's Disease Patients with Visual Hallucinations, International Journal of Neuroscience, 2010, 120, 8, 564

    CrossRef

  7. 7
    Gilles Fénelon, Thierry Soulas, Franck Zenasni, Laurent Cleret de Langavant, The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria, Movement Disorders, 2010, 25, 6
  8. 8
    Nico J. Diederich, Gilles Fénelon, Glenn Stebbins, Christopher G. Goetz, Hallucinations in Parkinson disease, Nature Reviews Neurology, 2009, 5, 6, 331

    CrossRef

  9. 9
    Christopher G. Goetz, Scales to evaluate psychosis in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S38

    CrossRef

  10. 10
    Ubaldo Bonuccelli, Roberto Ceravolo, The safety of dopamine agonists in the treatment of Parkinson's disease, Expert Opinion on Drug Safety, 2008, 7, 2, 111

    CrossRef

  11. 11
    Margaret A. Piggott, Clive G. Ballard, Elise Rowan, Clive Holmes, Ian G. McKeith, Evelyn Jaros, Robert H. Perry, Elaine K. Perry, Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline, Synapse, 2007, 61, 11